[1] |
HENG Bingbing, YANG Danfeng, DAI Shuyang, SHANGGUAN Wangning.
Propofol relieves the subcutaneous chloroquine-induced pruritus in rats via TRPV1 and CB1 receptors of spinal cord
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1101-1108.
|
[2] |
ZHENG Hongbo , YAO Wenlong , LUO Ailin, ZHOU Biyun.
Application of remimazolam combined with propofol in painless endoscopic retrograde cholangiopancreatography
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1154-1160.
|
[3] |
SHEN Yanping, YIN Lijun, ZHUANG Wenming, YAN Haiya.
Effective dose of esketamine for prevention on propofol injection pain in painless abortion
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 660-664.
|
[4] |
ZHAO Xin, LI Ding, WU Anshi.
Evaluation of the effect of propofol and desflurane on intracranial pressure in patients undergoing gynecological laparoscopic surgery based on the ratio of diameter of optic nerve sheath to transverse diameter of eyeball
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(12): 1408-1413.
|
[5] |
YANG Qinyan, HUANG Li, SHI Lan, OU Yuanyuan, LI Guoyuan, HUANG Chengyong.
Median effective plasma concentration of propofol inhibiting body movement when combined with butorphanol in patients undergoing hysteroscopic surgery
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 1033-1037.
|
[6] |
YANG Lu, WEI Bin, ZHANG Liping, BI Shanshan, LU Wei.
Response surface model to optimize the concentration range of propofol and remifentanil
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(4): 413-420.
|
[7] |
XIA Honglian, ZHONG Weiwei, JIN Peng, CHEN Meng, LIU Zaiying, ZHANG Yanli.
PI3K/AKT/GSK3β signaling pathway participates in the protective effect of adenosine A1R-mediated propofol on ischemia-reperfusion injury in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(12): 1344-1350.
|
[8] |
LIU Huanmiao, CHEN Zhuohui, WU Di, HUANG Xueting, WAN Qiquan.
Insulin attenuates the inhibition effect of lipopolysaccharide on Na+-K+-ATPase α1 via PI3K/AKT and PI3K/ERK pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(8): 896-902.
|
[9] |
HENG Bingbing, DAI Shuyang, YANG Danfeng, BEEKOO Deepti, LIAN Qingquan, SHANGGUAN Wangning.
Effects of propofol on spinal cord GRPR of intrathecal morphine-induced pruritus model in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(7): 759-765.
|
[10] |
XU Wenting, YANG Liqin, ZHANG Zhongnan, LIANG Jun, JIANG Nan, JIANG Miao, GUO Wenjun, WANG Mengya.
Psychophysiological observation of propofol addiction in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(6): 608-614.
|
[11] |
WU Min, GUO Yiyun, XIE Haitang.
Population pharmacokinetics of tamoxifen in patients with breast cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(4): 418-423.
|
[12] |
DU Tianping, MENG Zudong.
Mechanism of 17β-estradiol on p38MAPK signal transduction pathway in propofol-induced hippocampal neuronal apoptosis in developing rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(2): 128-133.
|
[13] |
YE Rongfang, LIU Mingyi, XU Yu, ZHANG Yanli, ZHU Dandan, DING Wei, XIONG Yuqing.
Effects of miR-1-3p/206/613 on the expression of LXRα and OATP1B1 proteins and its mechanism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(8): 846-854.
|
[14] |
ZHAO Pengcheng, XU Lili, LI Yanling.
Effects and safety of target controlled infusion of propofol combined with dexmetomidine in radiofrequency ablation of primary liver cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(6): 682-687.
|
[15] |
YUAN Lijialong, QIN Xuping.
ATP synthase beta subunit function and disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(4): 464-470.
|